Get Tested by visiting your doctor
Step 1. Print this page Step 2. Download Test Request Form Step 3. Visit your doctor...Tamoxifen
| Drug Category: | Antineoplastic |
| Drug Sub-Category: | Selective oestrogen receptor modulators |
GENE TEST(S) RECOMMENDED
Clinical Guidance
The test for Tamoxifen is recommended by the GenesFX clinical team, as it has been shown that this enzyme is important in how the drug is handled in the body.
Tamoxifen is metabolized by the genes found on the left
Tamoxifen is metabolized by the genes found on the left
....or Read More by clicking on "More Information" above
....or Read More by clicking on "More Information" above
....or Read More by clicking on "More Information" above
Why testing is important?
IN MEDICINE, ONE SIZE DOES NOT FIT ALL. TWO PEOPLE WHO TAKE THE SAME MEDICATION MAY HAVE VERY DIFFERENT RESPONSES.
Environment, diet, age, lifestyle and state of health can all influence a person's response to medicines, however strong evidence now suggests that genetic factors play an important role.
A simple genetic test can reduce the risk of side effects and provides doctors with another tool that they can use in clinical decision-making by;
- Finding the right drug and the right dose
- Safer use of medications by minimising Adverse Drug Reactions
- Improving therapeutic response to prescribed medications
Specific Gene Tests Available for Tamoxifen:
Group Gene Tests Available
DNAdose Test
DNA Dose tests for CYP2D6, CYP2C19, CYP2C9, VKORC1 all done simultaneously. This is recommended as many drugs are metabolised by more than one enzyme and many people are on more than one drug at a time.
Click on DNAdose above to find out more
...alternatively consider a single gene test
Single Gene Test(s) Available
Tests can be ordered as individual tests
Click on one of the test(s) above to find out more
Alternative Names:
| Apo-Tamox (Canada) | Gen-Tamoxifen (Canada) | Genox (Australia) |
| GenRx TamoxifenTamoxifen-Sandoz (Australia) | ICI-4674 (Alternative Generic Name) | Nolvadex (Australia) |
| Nolvadex-D (Australia) | Nolvadex-D (Canada) | Novadex (Canada) |
| Novadex (United States) | Novo-Tamoxifen (Canada) | NSC 180973 (Alternative Generic Name) |
| Soltamox (United States) | Soltamox (United Kingdom) | TAM (Alternative Generic Name) |
| Tamofen (Canada) | Tamosin (Australia) | Tamoxen (Australia) |
| Tamoxifen (Australia) | Tamoxifen Citrate (Alternative Generic Name) |
References
| Short | Full |
| Schroth W, Goetz MP, Hamann U, et al. (2009) | Schroth W, Goetz MP, Hamann U, et al. Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen. JAMA. 2009 Oct 7;302(13):1429-36. |